Treanda Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
CONCLUSION: This study underscores the importance of considering patient characteristics before administering ibrutinib as salvage therapy. Early relapse was associated with poor outcomes, highlighting the need for novel therapeutic strategies.PMID:38151961 | PMC:PMC10758639 | DOI:10.5045/br.2023.2023208 (Source: Blood Research)
Source: Blood Research - December 28, 2023 Category: Hematology Authors: Yong-Pyo Lee Ye Ji Jung Junhun Cho Young Hyeh Ko Won Seog Kim Seok Jin Kim Sang Eun Yoon Source Type: research